Jaguar Health Inc (NASDAQ:JAGX) traded at $0.21 at close of the session on Monday, April 29, made an upward move of 15.56% on its previous day’s price.
Looking at the stock we see that its previous close was $0.18. In terms of its 52-week price range, JAGX has a high of $1.22 and a low of $0.05. The company’s stock has gained about 131.37% over that past 30 days.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $2.3 million, with a low of $2.61 million and a high of $2.61 million. The median projection represents growth adding up to -29.40% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2023 is expected to hit $9.76 million, or -18.40% down from figures reported last year.
On the other hand, looking at the outlook for the JAGX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of Hold.
Looking further, we note the current price level is 64.03% off its SMA20 and 115.52% from its 50-day simple moving average. The RSI (14) is pointing at 71.12 while the volatility over the past week is 17.35% and jumps to 23.16% over the past one month. The beta value is 1.11, while the average true range (ATR) is currently pointing at 0.03.
Coming back to Jaguar Health Inc (NASDAQ:JAGX), we note that the average 3-month trading volume was 60.35 million. Current shares outstanding are 276.22 million.
The insiders hold 4.90% of the company’s shares while institutions hold 0.45%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 37.38% up in year-to-date price movement.
